NCT03574597: A reported trial by Novo Nordisk A/S
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03574597 |
|---|---|
| Title | SELECT - Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 24, 2018 |
| Completion date | June 21, 2023 |
| Required reporting date | June 20, 2024, midnight |
| Actual reporting date | June 18, 2024 |
| Date last checked at ClinicalTrials.gov | May 29, 2026 |
| Days late | None |